Loading news article.

Newsbenzinga

B. Riley Securities Maintains Buy on Anika Therapeutics, Raises Price Target to $21

Jul 30, 2026, 12:30 ET · Published

Article summary

Please check the source for details.

An excerpt from the original article.

Loading comments…